ActivistsInvestorsTrumpPoliticiansSerenityCitriniSemianalysis

ALNYLAM PHARMACEUTICALS INC

RNA-interference (RNAi) therapeutics

2 tracked filer(s) hold this · 0 opened, 1 added, 1 trimmed in 31-MAR-2026

Aggregate 13FScore 44 — mean of 2 scored holder(s) · buyers (new/add) avg 49. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Bridgewater49Added +24%106,592$35,268,0950.2%
Ancora38Trimmed -50%11$3,6400.0%

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-06-27.